Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan
· Delayed Price · Currency is TWD 18.20
+0.15 (0.83%)
May 16, 2025, 1:57 PM CST
TPEX:4431 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,759 | 1,293 | 1,472 | 291.62 | 1,024 | Upgrade
|
| Revenue Growth (YoY) | 36.02% | -12.14% | 404.61% | -71.51% | 156.92% | Upgrade
|
| Cost of Revenue | 1,537 | 1,101 | 1,232 | 251.48 | 395.12 | Upgrade
|
| Gross Profit | 221.55 | 192.35 | 239.4 | 40.14 | 628.52 | Upgrade
|
| Selling, General & Admin | 337.77 | 294.25 | 310.74 | 53.65 | 188.66 | Upgrade
|
| Research & Development | 2.86 | 12.3 | 16.4 | 1.98 | - | Upgrade
|
| Other Operating Expenses | -42.21 | -43.65 | -40.87 | -0.01 | -0.15 | Upgrade
|
| Operating Expenses | 299.09 | 264.17 | 286.15 | 55.6 | 190.27 | Upgrade
|
| Operating Income | -77.54 | -71.83 | -46.74 | -15.46 | 438.25 | Upgrade
|
| Interest Expense | -6.13 | -6.22 | -5.21 | -1.58 | -1.34 | Upgrade
|
| Interest & Investment Income | 2.89 | 2.3 | 1.15 | 0.67 | 0.55 | Upgrade
|
| Earnings From Equity Investments | -0.26 | 0.94 | 1.66 | -0.86 | -0.4 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.6 | 0.76 | 10.24 | -4.05 | -0.27 | Upgrade
|
| Other Non Operating Income (Expenses) | 18.26 | 20.05 | 20.9 | 0.15 | -2.18 | Upgrade
|
| EBT Excluding Unusual Items | -60.18 | -54 | -18.01 | -21.13 | 434.6 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -1.06 | 33.34 | 6.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | 17.51 | -4.1 | 8.68 | -0.16 | 0.15 | Upgrade
|
| Asset Writedown | -41.65 | 0.92 | -51.47 | -25.65 | - | Upgrade
|
| Pretax Income | -84.32 | -57.18 | -61.86 | -13.6 | 441.16 | Upgrade
|
| Income Tax Expense | 0.51 | 1.11 | 7.1 | 0.45 | 89.57 | Upgrade
|
| Earnings From Continuing Operations | -84.83 | -58.29 | -68.96 | -14.05 | 351.59 | Upgrade
|
| Minority Interest in Earnings | 2.46 | 2.07 | -22.94 | 0.04 | 0.68 | Upgrade
|
| Net Income | -82.38 | -56.22 | -91.9 | -14.01 | 352.27 | Upgrade
|
| Net Income to Common | -82.38 | -56.22 | -91.9 | -14.01 | 352.27 | Upgrade
|
| Net Income Growth | - | - | - | - | 3680.58% | Upgrade
|
| Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 33 | Upgrade
|
| Shares Change (YoY) | - | - | 0.00% | 11.05% | 3.86% | Upgrade
|
| EPS (Basic) | -2.25 | -1.54 | -2.52 | -0.38 | 10.97 | Upgrade
|
| EPS (Diluted) | -2.25 | -1.54 | -2.52 | -0.38 | 10.71 | Upgrade
|
| EPS Growth | - | - | - | - | 3625.23% | Upgrade
|
| Free Cash Flow | 22.75 | -26.03 | 36.98 | -16.46 | 252.76 | Upgrade
|
| Free Cash Flow Per Share | 0.62 | -0.71 | 1.01 | -0.45 | 7.68 | Upgrade
|
| Dividend Per Share | - | - | - | - | 3.333 | Upgrade
|
| Dividend Growth | - | - | - | - | 2450.34% | Upgrade
|
| Gross Margin | 12.60% | 14.88% | 16.27% | 13.76% | 61.40% | Upgrade
|
| Operating Margin | -4.41% | -5.56% | -3.18% | -5.30% | 42.81% | Upgrade
|
| Profit Margin | -4.68% | -4.35% | -6.25% | -4.80% | 34.41% | Upgrade
|
| Free Cash Flow Margin | 1.29% | -2.01% | 2.51% | -5.64% | 24.69% | Upgrade
|
| EBITDA | -2.48 | 4.65 | 36.75 | 23.65 | 460.78 | Upgrade
|
| EBITDA Margin | -0.14% | 0.36% | 2.50% | 8.11% | 45.01% | Upgrade
|
| D&A For EBITDA | 75.07 | 76.48 | 83.49 | 39.11 | 22.53 | Upgrade
|
| EBIT | -77.54 | -71.83 | -46.74 | -15.46 | 438.25 | Upgrade
|
| EBIT Margin | -4.41% | -5.56% | -3.18% | -5.30% | 42.81% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 20.30% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.